Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Tolfenamic acid

From Wikipedia, the free encyclopedia
Non-steroidal anti-inflammatory drug

Pharmaceutical compound
Tolfenamic acid
Clinical data
Trade namesClotam, Clotan, Tufnil, Migea
AHFS/Drugs.comInternational Drug Names
Routes of
administration
By mouth
ATC code
Legal status
Legal status
Identifiers
  • 2-[(3-chloro-2-methylphenyl)amino]benzoic acid)[2]
CAS Number
PubChemCID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard(EPA)
ECHA InfoCard100.033.862Edit this at Wikidata
Chemical and physical data
FormulaC14H12ClNO2
Molar mass261.71 g·mol−1
3D model (JSmol)
  • Clc2cccc(Nc1ccccc1C(=O)O)c2C
  • InChI=1S/C14H12ClNO2/c1-9-11(15)6-4-8-12(9)16-13-7-3-2-5-10(13)14(17)18/h2-8,16H,1H3,(H,17,18) checkY
  • Key:YEZNLOUZAIOMLT-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Tolfenamic acid is a member of theanthranilic acid derivatives (or fenamate) class ofNSAID drugs.[3] Like other members of the class, it is aCOX inhibitor and prevents formation ofprostaglandins.[4]

It is used in the UK as a treatment formigraine.[5][6] It is generally not available in the US.[4] It is available in some Asian, Latin American and European countries as ageneric drug for humans and for animals.[7]

Medical uses

[edit]

Tolfenamic acid finds utility in the prevention and treatment of conditions associated with pain and inflammation.[8][9] However, despite its efficacy when administered intramuscularly, subcutaneously, or orally,[10] TFA-based drugs have not yet gained approval in the United States and some other countries due to the significant number of reported side effects.[11][12]

Chemistry

[edit]

Tolfenamic acid, belonging to the pharmacological group of fenamates, possesses a chemical structure typical ofanthranilic acid derivatives. In this structure, one of the hydrogen atoms of the nitro group is substituted by a benzene ring featuring a methyl group and a chlorine atom at the ortho- and meta- positions, respectively.[13]

Nine forms of tolfenamic acid have been identified, some of which are determined by conformational states.[14][15][16] These polymorphic forms exhibit variations in the spatial arrangement within the unit cell and in the values of the C-N(H)-C-C angle.[16] This diversity in solid forms makes TFA an attractive candidate for modification and utilization in medical applications.

History

[edit]

It was discovered by scientists atMedica Pharmaceutical Company inFinland.[3]

Research

[edit]

Tolfenamic acid demonstrates the ability to inhibit the growth of cancer cells in the pancreas, sigmoid colon, and rectum.[17]

References

[edit]
  1. ^"Tolfenamic acid VMD".European Medicines Agency (EMA). 5 December 2024. Retrieved6 December 2024.
  2. ^Andersen KV, Larsen S, Alhede B, Gelting N, Buchardt O (1989)."Characterization of two polymorphic forms of tolfenamic acid, N-(2-methyl-3-chlorophenyl)anthranilic acid: their crystal structures and relative stabilities".J. Chem. Soc., Perkin Trans. 2 (10):1443–1447.doi:10.1039/P29890001443.
  3. ^abPentikäinen PJ, Neuvonen PJ, Backman C (1981). "Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent".European Journal of Clinical Pharmacology.19 (5):359–365.doi:10.1007/bf00544587.PMID 7238564.S2CID 9428076.
  4. ^abNIH LiverTox DatabaseMefenamic Acid Last updated June 23, 2015. Page accessed July 3, 2015. Quote: "(fenamates generally not available in the United States, such as tolfenamic acid and flufenamic acid)"
  5. ^NHSTolfenamic Acid (Tolfenamic acid 200mg tablets) Page accessed July 3, 2015
  6. ^"Virtual Medicinal Product (VMP) - Tolfenamic acid 200mg tablets - dm+d browser".dmd-browser.nhsbsa.nhs.uk. Retrieved23 April 2024.
  7. ^Drugs.comDrugs.com international listings for tolfenamic acid Page accessed July 3, 2015
  8. ^Kajander A, Laine V, Gothoni G (January 1972). "Effect of tolfenamic acid in rheumatoid arthritis".Scandinavian Journal of Rheumatology.1 (2):91–93.doi:10.3109/03009747209103003.PMID 4572954.
  9. ^Basha R, Baker CH, Sankpal UT, Ahmad S, Safe S, Abbruzzese JL, et al. (January 2011). "Therapeutic applications of NSAIDS in cancer: special emphasis on tolfenamic acid".Frontiers in Bioscience.3 (2):797–805.doi:10.2741/s188.PMID 21196413.
  10. ^Corum O, Corum DD, Er A, Yildiz R, Uney K (December 2018). "Pharmacokinetics and bioavailability of tolfenamic acid in sheep".Journal of Veterinary Pharmacology and Therapeutics.41 (6):871–877.doi:10.1111/jvp.12702.PMID 30084126.S2CID 51930602.
  11. ^Kjaersgård Rasmussen MJ, Holt Larsen B, Borg L, Soelberg Sørensen P, Hansen PE (June 1994). "Tolfenamic acid versus propranolol in the prophylactic treatment of migraine".Acta Neurologica Scandinavica.89 (6):446–450.doi:10.1111/j.1600-0404.1994.tb02664.x.PMID 7976233.S2CID 12334561.
  12. ^Isomäki H (October 1994). "Tolfenamic acid: clinical experience in rheumatic diseases".Pharmacology & Toxicology.75 (s2):64–65.doi:10.1111/j.1600-0773.1994.tb02001.x.PMID 7816786.
  13. ^López-Mejías V, Kampf JW, Matzger AJ (April 2009)."Polymer-induced heteronucleation of tolfenamic acid: structural investigation of a pentamorph".Journal of the American Chemical Society.131 (13):4554–4555.Bibcode:2009JAChS.131.4554L.doi:10.1021/ja806289a.PMC 2729806.PMID 19334766.
  14. ^Belov KV, Dyshin AA, Krestyaninov MA, Efimov SV, Khodov IA, Kiselev MG (December 2022). "Conformational preferences of tolfenamic acid in DMSO-CO2 solvent system by 2D NOESY".Journal of Molecular Liquids.367: 120481.doi:10.1016/j.molliq.2022.120481.S2CID 252630985.
  15. ^SeethaLekshmi S, Guru Row TN (1 August 2012). "Conformational Polymorphism in a Non-steroidal Anti-inflammatory Drug, Mefenamic Acid".Crystal Growth & Design.12 (8):4283–4289.Bibcode:2012CrGrD..12.4283S.doi:10.1021/cg300812v.ISSN 1528-7483.
  16. ^abCase DH, Srirambhatla VK, Guo R, Watson RE, Price LS, Polyzois H, et al. (5 September 2018). "Successful Computationally Directed Templating of Metastable Pharmaceutical Polymorphs".Crystal Growth & Design.18 (9):5322–5331.Bibcode:2018CrGrD..18.5322C.doi:10.1021/acs.cgd.8b00765.ISSN 1528-7483.
  17. ^Kim JH, Jung JY, Shim JH, Kim J, Choi KH, Shin JA, et al. (July 2010)."Apoptotic Effect of Tolfenamic Acid in KB Human Oral Cancer Cells: Possible Involvement of the p38 MAPK Pathway".Journal of Clinical Biochemistry and Nutrition.47 (1):74–80.doi:10.3164/jcbn.10-02.PMC 2901767.PMID 20664734.

External links

[edit]
pyrazolones /
pyrazolidines
salicylates
acetic acid derivatives
and related substances
oxicams
propionic acid
derivatives (profens)
n-arylanthranilic
acids (fenamates)
COX-2 inhibitors
(coxibs)
other
NSAID
combinations
Key:underline indicates initially developed first-in-class compound of specific group;#WHO-Essential Medicines;withdrawn drugs;veterinary use.
Alcohols
Barbiturates
Benzodiazepines
Carbamates
Flavonoids
Imidazoles
Kava constituents
Monoureides
Neuroactive steroids
Nonbenzodiazepines
Phenols
Piperidinediones
Pyrazolopyridines
Quinazolinones
Volatiles/gases
Others/unsorted
Receptor
(ligands)
DP (D2)Tooltip Prostaglandin D2 receptor
DP1Tooltip Prostaglandin D2 receptor 1
DP2Tooltip Prostaglandin D2 receptor 2
EP (E2)Tooltip Prostaglandin E2 receptor
EP1Tooltip Prostaglandin EP1 receptor
EP2Tooltip Prostaglandin EP2 receptor
EP3Tooltip Prostaglandin EP3 receptor
EP4Tooltip Prostaglandin EP4 receptor
Unsorted
FP (F)Tooltip Prostaglandin F receptor
IP (I2)Tooltip Prostacyclin receptor
TP (TXA2)Tooltip Thromboxane receptor
Unsorted
Enzyme
(inhibitors)
COX
(
PTGS)
PGD2STooltip Prostaglandin D synthase
PGESTooltip Prostaglandin E synthase
PGFSTooltip Prostaglandin F synthase
PGI2STooltip Prostacyclin synthase
TXASTooltip Thromboxane A synthase
Others
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Calcium
VDCCsTooltip Voltage-dependent calcium channels
Blockers
Activators
Potassium
VGKCsTooltip Voltage-gated potassium channels
Blockers
Activators
IRKsTooltip Inwardly rectifying potassium channel
Blockers
Activators
KCaTooltip Calcium-activated potassium channel
Blockers
Activators
K2PsTooltip Tandem pore domain potassium channel
Blockers
Activators
Sodium
VGSCsTooltip Voltage-gated sodium channels
Blockers
Activators
ENaCTooltip Epithelial sodium channel
Blockers
Activators
ASICsTooltip Acid-sensing ion channel
Blockers
Chloride
CaCCsTooltip Calcium-activated chloride channel
Blockers
Activators
CFTRTooltip Cystic fibrosis transmembrane conductance regulator
Blockers
Activators
Unsorted
Blockers
Others
TRPsTooltip Transient receptor potential channels
LGICsTooltip Ligand gated ion channels
Portal:


Stub icon

Thisdrug article relating to themusculoskeletal system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Tolfenamic_acid&oldid=1276275108"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp